Evidence map›Paper›PMID 35396476›Full record

ArticleNature methods2022

Advances in glycoscience to understand viral infection and colonization.

Amanda E Dugan, Amanda L Peiffer, Laura L Kiessling

Abstract read
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Genetic Characterization ofTransboundary and emerging diseases · 2024
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amanda E DuganDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Amanda L PeifferDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Laura L KiesslingDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. kiesslin@mit.edu.ORCID http://orcid.org/0000-0001-6829-1500

Funding

Synthetic Ligands for Modulating Immune Cell ResponsesR01AI055258 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KIESSLING, LAURA L · 2003 to 2024
$7.8M
Development of multifunctional probes for profiling microbial glycansU01CA231079 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI IMPERIALI, BARBARA, KIESSLING, LAURA L · 2018 to 2020
$1.4M
NCI NIH HHS U01 CA231079NIAID NIH HHS R01 AI055258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Virus DiseasesGlycosylationHumans

Identifiers

PMID35396476
PMCPMC11194102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.